# Arcturus Therapeutics Holdings Inc.: Form 8-K, filed Aug 7, 2023

- Company: [Arcturus Therapeutics Holdings Inc.](/companies/arct.md) (CIK 1768224)
- Form: 8-K
- Filed: 2023-08-07
- Accepted by EDGAR: Aug 7, 2023, 16:23 ET
- Period: 2023-08-07
- Accession: 0001193805-23-001112
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1768224/000119380523001112/e618839_8k-arct.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1768224/000119380523001112/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1768224/000119380523001112/e618839_8k-arct.htm

Filed Aug 7, 2023.
Source: SEC EDGAR, the filing index for accession 0001193805-23-001112. Last ingested by Listed: Nov 14, 2026, 14:45 ET. No prices; not investment advice.
